• Preventing Bacteria from Communicating Could Make CF Therapies Like Kalydeco More Effective, Study Reports
  • Why Aspiration Is a Silent, Hidden Danger for Cystic Fibrosis Patients
  • Burden of Caring for Children with CF Is Heavier with Mothers, Study Finds
  • Proteostasis’ CFTR Modulators Show Potential in Improving Effectiveness of Orkambi
  • Cystic Fibrosis Canada Starts Holiday Fundraiser Focusing on a Patient a Day Throughout December
  • ‘You’re So Lucky’: Respect Each Victory, and Know It Comes at a Price
  • Arch Biopartners Readies AB569, Potential Therapy for Lung Infections, for Planned Phase 1 Trial
  • Ontario Researcher Awarded Grant to Develop Precision Medicine Tool for CF
  • Kalydeco Seen as Safe in Treating Young Children, Ages 1 to 2, in Phase 3 Trial, Vertex Reports
  • UF Study Links Proton Pump Inhibitor Use with More Frequent Hospitalization in CF Patients
  • Virtual Reality Used In Hospital For Cystic Fibrosis ‘Distraction Therapy’
  • Scientists Explore New Way to Generate Stem Cell-like Cells for CF Therapy